Effect of Repositioning Frequency Neonates Receiving Phototherapy

NCT ID: NCT05692648

Last Updated: 2023-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-01

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort.

Design and methods: This was a single-centered, single-blind, 3-arm, pretest-posttest parallel-group randomized controlled trial conducted in a neonatal intensive care unit. Participants were randomly assigned to one of three groups: Supine position group (n = 20), hourly position change group (n = 20), and control group (n = 20). The bilirubin level and comfort levels of the neonates were evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bilirubinemia Newborn Jaundice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

single-centered, single-blind, 3-arm, pretest-posttest parallel-group randomized controlled trial
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
single (participant, outcomes assessor)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supine position group

These neonates were placed in supine position, fed every 2 hours in accordance with routine clinical practice, and then returned to supine position.

Group Type EXPERIMENTAL

Supine position group

Intervention Type BEHAVIORAL

These neonates were placed in supine position, fed every 2 hours in accordance with routine clinical practice, and then returned to supine position.

Hourly position change group:

Infants in this group were repositioned "every hour" based on the time of phototherapy initiation. Neonates were initially placed in supine position and then changed to the prone position. Infants were alternated between supine and prone positions every hour for 24 hours.

Group Type EXPERIMENTAL

Hourly position change group

Intervention Type BEHAVIORAL

Infants in this group were repositioned "every hour" based on the time of phototherapy initiation. Neonates were initially placed in supine position and then changed to the prone position. Infants were alternated between supine and prone positions every hour for 24 hours.

Control Group (2-hour position change)

Neonates in this group were repositioned every 2 hours as routine practice based on the time of phototherapy initiation.

Group Type OTHER

Control Group (2-hour position change)

Intervention Type BEHAVIORAL

Neonates in this group were repositioned every 2 hours as routine practice based on the time of phototherapy initiation. Phototherapy was started with neonates in supine position. In the second period, the neonate was placed in the prone position after routine feeding was performed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supine position group

These neonates were placed in supine position, fed every 2 hours in accordance with routine clinical practice, and then returned to supine position.

Intervention Type BEHAVIORAL

Hourly position change group

Infants in this group were repositioned "every hour" based on the time of phototherapy initiation. Neonates were initially placed in supine position and then changed to the prone position. Infants were alternated between supine and prone positions every hour for 24 hours.

Intervention Type BEHAVIORAL

Control Group (2-hour position change)

Neonates in this group were repositioned every 2 hours as routine practice based on the time of phototherapy initiation. Phototherapy was started with neonates in supine position. In the second period, the neonate was placed in the prone position after routine feeding was performed.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* gestational age between 35-42 weeks
* birth weight of 2000 g or more
* indication for phototherapy
* no previous phototherapy,
* no medical diagnosis other than prenatal hyperbilirubinemia
* stable health status
* no clinical signs of dehydration
* transition to oral feeding, no sucking problems
* being at least 2 days old on the day of phototherapy

Exclusion Criteria

* a sudden change in stability during phototherapy and
* phototherapy duration of less than 24 hours
Minimum Eligible Age

35 Weeks

Maximum Eligible Age

42 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Selcuk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sevinc Akkoyun

lecturer (Phd)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sibel Kücükoglu, professor

Role: STUDY_DIRECTOR

Selcuk University

Fatma Tas Arslan, professor

Role: STUDY_DIRECTOR

Selcuk University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Selcuk University

Konya, Selcuklu/Konya, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019/14489

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hyperbilirubinemia in Full-term Neonates
NCT06238349 RECRUITING PHASE4
Cycled Phototherapy
NCT03927833 ACTIVE_NOT_RECRUITING NA
Value of Transcutaneous Bilirubin Devices
NCT06232174 NOT_YET_RECRUITING